This is a news story, published by Yahoo, that relates primarily to Zepbound news.
For more Zepbound news, you can click here:
more Zepbound newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Yahoo, you can click here:
more news from YahooOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
Mounjaro prescription. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest obesity treatment news, Mounjaro news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Weight Loss MedicationVerywell Health
•69% Informative
Mounjaro (tirzepatide) is a once- weekly injectable medication that the FDA has approved to help manage blood sugar levels in adults with type 2 diabetes.
The FDA has not approved it for weight loss specifically, but it can be prescribed off-label.
In November 2023 , the FDA approved a new drug called Zepbound specifically for weight-loss in people who are obese or overweight with a weight-related condition.
Mounjaro is a once- weekly injectable medicine that can help control blood sugar in people with type 2 diabetes.
Ozempic (semaglutide) is also prescribed off-label for weight management.
In a 40-week study, tirzepatide was more effective at lowering blood sugar levels.
Mounjaro is an injectable medication approved for managing blood sugar in people with type 2 diabetes.
It's not officially approved for weight loss, but it can sometimes be prescribed off-label for this purpose.
Some of the most common side effects of tirzepatide include nausea, vomiting, and diarrhea.
VR Score
50
Informative language
38
Neutral language
70
Article tone
informal
Language
English
Language complexity
55
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
19
Source diversity
2
Affiliate links
no affiliate links